180 Life Sciences (ATNF)
NASDAQ:ATNF
US Market
Holding ATNF?
Track your performance easily

180 Life Sciences (ATNF) Income Statement

270 Followers

180 Life Sciences Income Statement

Last quarter (Q ), 180 Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q, 180 Life Sciences's net income was $11.78K. See 180 Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-----$ 2.88M
Cost of Revenue
------
Gross Profit
-----$ 2.88M
Operating Expense
$ 8.93M$ 13.48M$ 17.90M$ 15.64M$ 5.65M$ 20.86M
Operating Income
$ -8.93M$ -13.48M$ -17.90M$ -15.64M$ -5.65M$ -20.86M
Net Non Operating Interest Income Expense
$ -4.57K$ -44.83K$ 26.67K$ -25.43K$ -1.09M$ -3.51M
Other Income Expense
$ -11.45M$ -8.76M$ -21.74M$ 4.41M$ 4.17M$ 701.47K
Pretax Income
$ -14.90M$ -22.28M$ -39.67M$ -20.35M$ -10.90M$ -25.40M
Tax Provision
$ -2.35M$ -2.35M$ -942.75K$ -23.20K$ -20.43K$ -9.50K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -12.55M$ -19.94M$ -38.73M$ -20.32M$ -12.01M$ -25.39M
Basic EPS
$ -16.74$ -52.59$ -387.22$ -12.35$ -12.54$ -0.02
Diluted EPS
$ -16.74$ -52.59$ -352.45$ -12.35$ -12.54$ -0.02
Basic Average Shares
$ 2.60M$ 379.09K$ 100.02K$ 1.65M$ 955.48K$ 4.22M
Diluted Average Shares
$ 2.60M$ 379.09K$ 100.02K$ 1.65M$ 955.48K$ 4.22M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 8.93M$ 13.48M$ 17.90M$ 15.64M$ 5.65M$ 20.86M
Net Income From Continuing And Discontinued Operation
$ -12.55M$ -19.94M$ -38.73M$ -20.32M$ -10.88M$ -25.39M
Normalized Income
$ -7.27M$ -15.57M-$ -21.30M--
Interest Expense
------
EBIT
$ -14.85M$ -22.24M$ -39.64M$ -20.32M$ -9.82M$ -25.22M
EBITDA
$ -14.49M$ -22.13M$ -39.53M$ -20.21M$ -9.69M$ -25.15M
Currency in USD

180 Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis